Xamoterol in hypertrophic cardiomyopathy: effects on diastolic function and heart rate.
The aims of this study were to determine the effects of the partial beta 1-adrenergic agonist, xamoterol, on diastolic function and ambulatory heart rate in hypertrophic cardiomyopathy. Eleven patients with non-obstructive hypertrophic cardiomyopathy were studied with cross-sectional and Doppler echocardiography and 24-h Holter monitoring before and after a single intravenous dose of xamoterol. Resting heart rate (mean +/- SD) increased from 76 +/- 16 before, to 83 +/- 15 beats/min 15 min after xamoterol, p = 0.03. In the 4-h period after xamoterol, maximum heart rate was reduced (127 +/- 21 to 112 +/- 19, p = 0.01) and minimum heart increased (60 +/- 16 to 67 +/- 17, p = 0.04) compared to the same 4-h period of the previous day. There were no significant changes in cross-sectional or Doppler echocardiographic measurements of left ventricular function following xamoterol. Xamoterol stabilises the heart rate in hypertrophic cardiomyopathy. The absence of a significant effect on Doppler measurements does not preclude a beneficial effect on diastolic function. This initial study suggests that xamoterol should be further investigated as a new medical therapy for hypertrophic cardiomyopathy.